Showing results (211-220 of 230) with videos related to
Sort By:
Pageof 23
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 5, 2024
The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancerJonah M Levine, Ingmar F Rompen, Jorge Campos Franco, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 9, 2020
The Stanford acute heart failure symptom score for patients hospitalized with heart failureChristopher S Almond, Sharon Chen, John C Dykes, et al.JAMA Surgery|June 13, 2014
Evaluation of hospital readmissions in surgical patients: do administrative data tell the real story?Greg D Sacks, Aaron J Dawes, Marcia M Russell, et al.World Journal of Surgery|December 9, 2024
Longitudinal assessment of disparities in pancreatic cancer care: A retrospective analysis of the National Cancer DatabaseMahip Grewal, Victor J Kroon, Sarah R Kaslow, et al.AJR. American Journal of Roentgenology|May 6, 2026
Leveraging Fine-Tuned Large Language Models for Interpretable Pancreatic Cystic Lesion Feature Extraction and Risk CategorizationEbrahim Rasromani, Stella K Kang, Yanqi Xu, et al.Annals of Surgical Oncology|June 30, 2025
The APROVE (Anti-coagulation/Platelet Treatment in Pancreatic Resections Involving Vascular Reconstruction) Study: Results from a Worldwide SurveyAlessio Marchetti, Jonathan Garnier, Joseph R Habib, et al.Developmental Cognitive Neuroscience|March 8, 2026
Bridging the gap: Translating fetal, infant, and toddler neuroimaging insights into clinical practicePaige M Nelson, Dashiell D Sacks, Marta Korom, et al.JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.Journal of Gastroenterology and Hepatology|August 1, 2024
Outcomes in intraductal papillary mucinous neoplasm-derived pancreatic cancer differ from PanIN-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Ammar A Javed, et al.Journal of the National Cancer Institute|July 19, 2024
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancerJoseph R Habib, Ingmar F Rompen, Brady A Campbell, et al.Pageof 23